Skip to main content
U2BIO CO., LTD. logo

U2BIO CO., LTD. — Investor Relations & Filings

Ticker · 221800 ISIN · KR7221800006 KO Human health and social work activities
Open in API
Filings indexed 227 across all filing types
Latest filing 2022-06-03 Annual Report
Country KR South Korea
Listing KO 221800

About U2BIO CO., LTD.

https://www.u2bio.co.kr/eng/main.do

U2BIO CO., LTD. is a healthcare technology company specializing in the integration of biotechnology (BT) and information technology (IT). The company provides a range of in vitro diagnostic services, including clinical laboratory tests and molecular diagnostics. Concurrently, it develops and offers digital healthcare solutions and medical IT services tailored for medical institutions such as hospitals and clinics. U2BIO focuses on delivering personalized healthcare services based on scientific data to support medical professionals and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for an Annual Report (사업보고서) filed by U2BIO Co., Ltd. It explicitly lists the corrections made to the financial statements, notes, and other disclosures of the original Annual Report. Since it contains substantive financial data and is a formal amendment to the company's primary annual filing, it is classified as an Annual Report (10-K). FY 2020
2022-06-03 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by U2Bio. It lists the date, location, attendees, and agenda of the meeting. Since it is a short regulatory announcement confirming that an IR event took place and where the materials can be found, rather than the presentation slides themselves, it falls under the category of a regulatory filing announcement.
2022-05-17 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation materials themselves or a transcript of the event, it falls under the category of a regulatory announcement regarding corporate activities.
2022-05-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a standard regulatory disclosure for insider shareholdings, which falls under the 'Director's Dealing' category as it reports the acquisition of shares by a newly appointed executive (Kim Hee Chan).
2022-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (Annual General Meeting). It details the approval of financial statements, dividend resolutions, election of directors, and other agenda items. This fits the definition of a Declaration of Voting Results (DVA), as it reports the outcome of shareholder votes at a general meeting.
2022-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled 'Report on the Appointment, Dismissal, or Resignation of Outside Directors' (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). It details the appointment of new outside directors for the company U2Bio. This falls under the category of Board/Management Information, which covers changes in the board of directors.
2022-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.